Rogers, Jr. v. Social Security Administration Commissioner

CourtDistrict Court, W.D. Arkansas
DecidedJanuary 30, 2023
Docket2:21-cv-02150
StatusUnknown

This text of Rogers, Jr. v. Social Security Administration Commissioner (Rogers, Jr. v. Social Security Administration Commissioner) is published on Counsel Stack Legal Research, covering District Court, W.D. Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rogers, Jr. v. Social Security Administration Commissioner, (W.D. Ark. 2023).

Opinion

IN THE UNITED STATES DISTRICT COURT WESTERN DISTRICT OF ARKANSAS FORT SMITH DIVISION

ROY W. ROGERS, JR. PLAINTIFF v. Civil No. 2:21-cv-02150-PKH-MEF KILOLO KIJAKAZI, Acting Commissioner, Social Security Administration DEFENDANT

MAGISTRATE JUDGE’S REPORT AND RECOMMENDATION Plaintiff, Roy W. Rogers, Jr., brings this action under 42 U.S.C. § 405(g), seeking judicial review of a decision of the Commissioner of Social Security Administration (the “Commissioner”) denying his claim for a period of disability and disability insurance benefits (“DIB”) under Title II of the Social Security Act (hereinafter “the Act”), 42 U.S.C. § 423(d)(1)(A). In this judicial review, the Court must determine whether there is substantial evidence in the administrative record to support the Commissioner’s decision. See 42 U.S.C. § 405(g). I. Procedural Background Plaintiff filed his application for benefits on January 4, 2019, alleging disability beginning January 27, 2018, due to blindness in his left eye, glaucoma, heart attack, abnormalities in the heart, tubal shunt in the right eye, and swelling in the feet. (ECF No. 12, pp. 12-24, 181). Plaintiff was 47 years old on the alleged disability date, has a limited education, and is unable to perform any past relevant work. (Id., p. 28). His application was denied initially and on reconsideration. (Id., pp. 17, 106-108, 110-111). At Plaintiff’s request, an Administrative Law Judge (“ALJ”), Elisabeth McGee, held an administrative hearing on June 8, 2020, via telephone due to the extraordinary circumstance presented by the COVID-19 pandemic. (Id., pp. 35-70). Plaintiff was present and represented by counsel. On September 3, 2020, the ALJ concluded that Plaintiff’s severe glaucoma, right eye with tube stent and moderate visual field loss, left eye with almost total visual field loss, depressive

disorder, and anxiety disorder were severe, but she concluded these impairments did not meet or medically equal one of the listed impairments in Appendix 1, Subpart P, Regulation No. 4. (ECF No. 12, pp. 14-15). She found Plaintiff capable of performing: light work as defined in 20 C.F.R. § 404.1567(a) except he can frequently bend, stoop, and crawl. Due to loss of vision in the left eye, he is limited to no moving mechanical parts from the left. The claimant is limited to no jobs requiring the use of both eyes or excellent vision and no bright light or sunshine. He can perform simple, routine, repetitive tasks and make simple work-related decisions. (Id., pp. 17-21).

With the assistance of a vocational expert (“VE”), the ALJ concluded that Plaintiff could perform work as a collator operator, DOT 208.685-101, which is classified as light, unskilled work, and of which there are 46,849 jobs in the national economy; a photo copy machine operator, DOT 207.685-014, which is classified as light, unskilled work, and of which there are 10,381 jobs in the national economy; and an office helper, DOT 239.567-101, which is classified as light, unskilled work, and of which there are 13,843 jobs in the national economy. (Id., p. 29). Plaintiff was found not to be under a disability from his alleged onset date through the date of the ALJ’s decision. (Id.). The Appeals Council denied Plaintiff’s request for review on July 22, 2021. (ECF No. 12, pp. 6-10). Plaintiff then filed his Complaint to initiate this action on September 21, 2021. (ECF No. 2). This matter is before the undersigned for report and recommendation. Both parties have filed appeal briefs (ECF Nos. 15, 16), and the case is ready for decision. II. Relevant Evidence The undersigned has conducted a thorough review of the entire record in this case. Because Plaintiff’s appeal primarily concerns whether his visual impairments prevent him from a limited range of light work, the undersigned will only recount the evidence relevant to that claim.

The 1,022-page record in this case includes objective medical evidence and treatment notes, opinion evidence, and Plaintiff’s subjective statements to the Agency regarding his limitations. The relevant medical evidence demonstrates a history of eye impairments requiring surgeries and medications followed by conservative and effective treatment modalities for Plaintiff’s symptoms. In October 2018, Plaintiff sought treatment with Steven Vold, M.D., for decreased vision, left eye more than the right, and unclear vision especially when reading, watching television, looking at a computer, and driving. (ECF No. 12, pp. 389-407). Dr. Vold noted Plaintiff’s history of glaucoma in both eyes; trabeculectomies with an antifibrotic agent in the left eye; tube shunt placement, patch graft, and complex phacoemulsification with PCIOL in the right eye; and an yttrium-aluminum-garnet laser

capsulotomy of the right eye. (Id., p. 389). Dr. Vold noted a gap in treatment of 23 months despite this eventful medical history. (Id.). Plaintiff reported general compliance with ocular prescriptions for brinzolamide, Lumigan, and dorzolamide. (Id.). He explained that some of the medications caused itching and redness of his eye lids. (Id.). Testing showed severe stage primary open-angle glaucoma of both eyes, pseudophakia in the right eye, and cortical cataract in the left eye. (Id., p. 407). As to his treatment plan, Plaintiff’s medications were adjusted in response to the reported side effects, and Dr. Vold emphasized the importance of improved medical compliance and follow- up. (Id.). Plaintiff sought treatment with Dr. Vold again in August 2019, reporting difficulty seeing in dim lighting, difficulty with glare, poor peripheral vision, and progressive loss of vision. (ECF No. 12, pp. 776-779). Dr. Vold noted that he last saw Plaintiff approximately nine months prior and assessed Plaintiff with severe stage open-angle glaucoma of both eyes, dermatochalasis of

both upper eyelids, pseudophakia of the right eye, and symptomatic cortical cataract of the left eye. (Id., p. 779). Plaintiff stated that he was only generally compliant with his glaucoma medication, but explained that he had problems tolerating some of them. (Id., p. 776). Dr. Vold adjusted Plaintiff’s medications and discussed the risks and benefits of surgery, namely phacoemulsification with goniotomy of the left eye. (Id.). Plaintiff understood and wished to proceed with surgery. (Id.). Eight days after surgery, Plaintiff described good, fairly stable vision and complained of no issues. (ECF No. 12, pp. 783-785). He stated that he always used his medications as directed. (Id.). Throughout September and October 2019, Plaintiff continued to report good, fairly stable vision and claimed to use his medications as directed. (Id., pp. 786-797).

When Plaintiff complained of photophobia and poor vision in November 2019, he also admitted to never using his medications as directed. (ECF No. 12, pp. 883-889). Plaintiff’s only ocular medication at this point was netarsudil-latanoprost, which he was instructed to administer by dropping one drop into both eyes at bedtime. (Id., p. 883). Examination and testing remained consistent with primary open-angle glaucoma with central corneal thickness within normal limits. (Id., pp. 884-889). Dr. Vold continued Plaintiff’s medication. (Id., p. 889). Ten weeks later, in January 2020, Plaintiff returned to Dr. Vold with complaints of burning and stinging when using the prescribed eye drops. (ECF No. 12, pp. 890-892). He reported being very compliant with his medication but was moderately bothered by the side effects that occurred every time he used the drops.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Vossen v. Astrue
612 F.3d 1011 (Eighth Circuit, 2010)
Jones v. Astrue
619 F.3d 963 (Eighth Circuit, 2010)
Wilburn v. Astrue
626 F.3d 999 (Eighth Circuit, 2010)
Johnson v. Astrue
627 F.3d 316 (Eighth Circuit, 2010)
David Perks v. Michael J. Astrue
687 F.3d 1086 (Eighth Circuit, 2012)
Royce McDade v. Michael J. Astrue
720 F.3d 994 (Eighth Circuit, 2013)
Casey v. Astrue
503 F.3d 687 (Eighth Circuit, 2007)
Ford v. Astrue
518 F.3d 979 (Eighth Circuit, 2008)
Davidson v. Astrue
578 F.3d 838 (Eighth Circuit, 2009)
Robert Blackburn v. Carolyn W. Colvin
761 F.3d 853 (Eighth Circuit, 2014)
Rick Whitman v. Carolyn W. Colvin
762 F.3d 701 (Eighth Circuit, 2014)
Charles Miller v. Carolyn W. Colvin
784 F.3d 472 (Eighth Circuit, 2015)
Robert Karlix v. Jo Anne B. Barnhart
457 F.3d 742 (Eighth Circuit, 2006)

Cite This Page — Counsel Stack

Bluebook (online)
Rogers, Jr. v. Social Security Administration Commissioner, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rogers-jr-v-social-security-administration-commissioner-arwd-2023.